Keyword Analysis & Research: icpt today's stock price
Keyword Research: People who searched icpt today's stock price also searched
Search Results related to icpt today's stock price on Search Engine
VERU - Veru Stock Price - Barchart.com
It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. Price/Cash Flow: Latest closing price divided by …
DA: 35 PA: 72 MOZ Rank: 70
Biotech Stock Roundup: ICPT's Study Data, NVAX Vaccine Gets …
Jul 14, 2022 · Toward the end of 2021, Bank of America traded at its highest stock price since 2007, at more than $49 per share, albeit it was a period when most stocks traded at …
DA: 13 PA: 44 MOZ Rank: 18
VAR1 Stock Forecast, Price & News (Varta) - MarketBeat
Aug 08, 2022 · Their VAR1 share price forecasts range from €64.00 to €102.00. On average, they expect the company's share price to reach €79.94 in the next year. This suggests that the stock has a possible downside of 0.7%. View analysts price targets for VAR1 or view top-rated stocks among Wall Street analysts.
DA: 90 PA: 45 MOZ Rank: 92
Intercept Pharma (ICPT) Tops Q2 EPS by 21c; Offers FY22 Revenue …
Aug 03, 2022 · Intercept Pharma (NASDAQ: ICPT) reported Q2 EPS of ($0.25), $0.21 better than the analyst estimate of ($0.46). Revenue for the quarter came in at $71.76 million versus the consensus estimate of ...
DA: 21 PA: 74 MOZ Rank: 93
LXRX Stock Forecast, Price & News (Lexicon Pharmaceuticals)
Aug 09, 2022 · 1 Wall Street research analysts have issued 1-year price targets for Lexicon Pharmaceuticals' stock. Their LXRX share price forecasts range from $20.00 to $20.00. On average, they anticipate the company's stock price to reach $20.00 in the next year. This suggests a possible upside of 693.7% from the stock's current price.
DA: 83 PA: 31 MOZ Rank: 68
Intercept (ICPT) Reports Positive Data From NASH Study on OCA
Jul 08, 2022 · You can see the complete list of today’s Zacks #1 Rank stocks here. Aquestive Therapeutics’loss per share estimates for 2022 have narrowed …
DA: 38 PA: 76 MOZ Rank: 25
Intercept Pharmaceuticals (ICPT) Reports Q2 Loss, Beats Revenue
Aug 05, 2022 · Intercept Pharmaceuticals (ICPT) came out with a quarterly loss of $0.68 per share versus the Zacks Consensus Estimate of a loss of $0.53. This compares to loss of $0.33 per share a year ago ...
DA: 59 PA: 77 MOZ Rank: 66
Intercept (ICPT) Earnings Miss, Sales Top Estimates in Q2 (Revised)
Aug 05, 2022 · Intercept Pharmaceuticals, Inc. (ICPT) incurred a loss of 68 cents per share (from continuing operations) in second-quarter 2022, wider than the Zacks Consensus Estimate of a loss of 53 cents ...
DA: 78 PA: 19 MOZ Rank: 48
7 Biotech Stocks to Buy for Q3 | InvestorPlace
Jul 18, 2022 · The stock was once a high-flier, having skyrocketed to just under $110 in 2019. Since then, stung by not-so-enterprising pipeline updates, the stock has pulled back notably.
DA: 92 PA: 99 MOZ Rank: 13
Viking Therapeutics - VKTX Stock Forecast, Price & News
Aug 09, 2022 · 5 brokerages have issued 1-year price targets for Viking Therapeutics' stock. Their VKTX share price forecasts range from $10.00 to $15.00. On average, they expect the company's stock price to reach $13.50 in the next twelve months. This suggests a possible upside of 297.1% from the stock's current price.
DA: 34 PA: 81 MOZ Rank: 28